GENETIC INTELLIGENCE

Biotech · Private

AI software platform that analyzes whole genome sequencing data to identify causative genetic mutations in inherited diseases

geneticintelligence.com →
Grants
$225K
1 award
Sector median: 1
Raised
—
No Form D on record
Contracts
—
No federal contracts on record
Patents
17
0 granted · 17 pending
Sector median: 2

Capital Timeline

Federal above the line · equity below · node area scaled to amount
Capital and federal award history
DateEventSourceAmount
Federal grantNational Science Foundation · Phase I · SBIR Phase I: Platform to Elucidate the Causal Mutations Behind Human Inherited Diseases$225,000
Federal grant · SBIR/STTR

Peer position

Biotech · 4373 companies · ranked on federal contract value
Biotech companies ranked by federal contract value
#CompanyContractsDisclosed equity
1282ADVANCED VIROLOGY INC.——
1283IMMUNE MODULATORY THERAPIES, LLC——
1284XLOCK BIOSCIENCES, LLC——
1285GENETIC INTELLIGENCE——
1286BINARY GENOMICS, INC.——
1287ELIXERA, INC.——
1288Distributed Bio, Inc.——

Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.

Patents

USPTO · 0 granted of 17
  • Pyridazinone-derived Compounds For The Modulation Of Myc And For Medical Usesapplication
  • Compositions For Flcn Gene Modulation And Methods Thereofapplication
  • Compositions for FNIP1/FNIP2 Gene Modulation and Methods Thereofapplication
  • Methods For Decentralized Genome Storage, Distribution, Marketing And Analysisapplication
  • Methods For Data Segmentation And Identificationapplication
  • Convolutional Artificial Neural Networks, Systems And Methods Of Useapplication
  • Compositions for FLCN Gene Modulation and Methods Thereofapplication
  • Methods For Data Segmentation And Identificationapplication
  • Methods For Decentralized Genome Storage, Distribution, Marketing And Analysisapplication
  • Methods For Identifying Genetic Causation Of Complex Traitsapplication
  • Generation Of Adaptive Csnp Maps To Identify And Predict Phenotype-causing Genesapplication
  • Compositions For Modulation Of IL-2 And Methods Thereofapplication

Regulatory activity · Biotech

Sector-level, not company-level

Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.